Add like
Add dislike
Add to saved papers

Repellent Effects of Encapsulated Carvacrol on the Rhipicephalus (Boophilus) microplus (Acari: Ixodidae).

Rhipicephalus (Boophilus) microplus (Canestrini) is a problem for livestock production systems, and its control has become challenging due to the selection of tick populations resistant to synthetic chemical acaricides. The use of repellent compounds prevents contact between the arthropod parasite and the host and can, thus, contribute to increases in the efficacy of these acaricides. Carvacrol monoterpenic phenol is a possible alternative method for controlling R. (B.) microplus; however, this compound is highly volatile, and its volatilization can be decreased through microencapsulation, which results in the timed release of the compound. The cell wall of Saccharomyces cerevisiae can be utilized for the protection of volatile molecules. The aim of this study was to evaluate the in vitro repellent effect of yeast cell wall-encapsulated carvacrol on susceptible R. (B.) microplus larvae. Specifically, the vertical filter paper bioassay was employed to analyze the repellent activity of encapsulated carvacrol, nonencapsulated carvacrol, and N,N-diethyl-meta-toluamide at concentrations ranging from 0.75 to 0.001 mg/cm2, and the repellent activities were evaluated. Both carvacrol and encapsulated carvacrol exhibited repellent effects on R. (B.) microplus larvae, and the encapsulated compound showed the highest repellent activities at the lowest concentrations. Carvacrol encapsulated exhibited a low repellent concentration in all times (≤0.05 mg/cm2), whereas the carvacrol nonencapsulated ranged CR50 from 0.13 to 0.27 mg/cm2 at 1- to 6-h posttreatment. The present paper provides the first description of the use of a microencapsulation technique for achieving the highest repellent effect of carvacrol and indicates that this technique might be used to obtain new delivery systems for volatile and hydrophobic compounds.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app